rs7049300
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_181332.3(NLGN4X):c.933C>T(p.Thr311=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.119 in 1,209,508 control chromosomes in the GnomAD database, including 6,131 homozygotes. There are 46,435 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 751 hom., 4089 hem., cov: 22)
Exomes 𝑓: 0.12 ( 5380 hom. 42346 hem. )
Consequence
NLGN4X
NM_181332.3 synonymous
NM_181332.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.375
Genes affected
NLGN4X (HGNC:14287): (neuroligin 4 X-linked) This gene encodes a member of the type-B carboxylesterase/lipase protein family. The encoded protein belongs to a family of neuronal cell surface proteins. Members of this family may act as splice site-specific ligands for beta-neurexins and may be involved in the formation and remodeling of central nervous system synapses. The encoded protein interacts with discs large homolog 4 (DLG4). Mutations in this gene have been associated with autism and Asperger syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant X-5903745-G-A is Benign according to our data. Variant chrX-5903745-G-A is described in ClinVar as [Benign]. Clinvar id is 95987.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-5903745-G-A is described in Lovd as [Likely_benign]. Variant chrX-5903745-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.375 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.173 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NLGN4X | NM_181332.3 | c.933C>T | p.Thr311= | synonymous_variant | 5/6 | ENST00000381095.8 | NP_851849.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NLGN4X | ENST00000381095.8 | c.933C>T | p.Thr311= | synonymous_variant | 5/6 | 1 | NM_181332.3 | ENSP00000370485 | P4 |
Frequencies
GnomAD3 genomes AF: 0.129 AC: 14341AN: 111235Hom.: 751 Cov.: 22 AF XY: 0.122 AC XY: 4074AN XY: 33463
GnomAD3 genomes
AF:
AC:
14341
AN:
111235
Hom.:
Cov.:
22
AF XY:
AC XY:
4074
AN XY:
33463
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.108 AC: 19778AN: 183403Hom.: 794 AF XY: 0.110 AC XY: 7440AN XY: 67837
GnomAD3 exomes
AF:
AC:
19778
AN:
183403
Hom.:
AF XY:
AC XY:
7440
AN XY:
67837
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.118 AC: 129368AN: 1098219Hom.: 5380 Cov.: 34 AF XY: 0.116 AC XY: 42346AN XY: 363575
GnomAD4 exome
AF:
AC:
129368
AN:
1098219
Hom.:
Cov.:
34
AF XY:
AC XY:
42346
AN XY:
363575
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.129 AC: 14357AN: 111289Hom.: 751 Cov.: 22 AF XY: 0.122 AC XY: 4089AN XY: 33527
GnomAD4 genome
AF:
AC:
14357
AN:
111289
Hom.:
Cov.:
22
AF XY:
AC XY:
4089
AN XY:
33527
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 16, 2013 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 26, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at